[Posttherapeutic Quality of Life After Treatment of Salivary Gland Cancer]

Overview

Journal HNO

Specialty Otorhinolaryngology

Date 2023 Feb 24

PMID 36826483

Authors

Valentin Burkhardt

Christoph Becker

Affiliations

Soon will be listed here.

Abstract

Background: In addition to overall survival and recurrence-free interval, posttherapeutic quality of life has been established as an independent criterion for treatment evaluation. Thereby, both the specific changes in the head and neck region and their objectification represent a particular challenge for the assessment of quality of life. There are different validated questionnaires available.

Objective: Based on the literature, an overview of the relevant questionnaire instruments is given and the specific aspects in patients with salivary gland cancer are presented.

Materials And Methods: A selective literature search was conducted to collect publications dealing with the assessment of health-related quality of life in head and neck tumor patients. The papers were critically appraised and summarized.

Results: There are some validated questionnaires available to measure quality of life in patients with head and neck tumors as well as a few specific questionnaires for patients after parotidectomy.

Conclusion: By assessing quality of life using standardized questionnaire instruments, disease and treatment consequences can be objectified. Thus, the need for supportive measures, e.g., for rehabilitation in facial nerve palsy, can be identified more reliably.

References

Heutte N, Plisson L, Lange M, Prevost V, Babin E . Quality of life tools in head and neck oncology. Eur Ann Otorhinolaryngol Head Neck Dis. 2013; 131(1):33-47. DOI: 10.1016/j.anorl.2013.05.002. View

So W, Chan R, Chan D, Hughes B, Chair S, Choi K . Quality-of-life among head and neck cancer survivors at one year after treatment--a systematic review. Eur J Cancer. 2012; 48(15):2391-408. DOI: 10.1016/j.ejca.2012.04.005. View

Murphy B, Ridner S, Wells N, Dietrich M . Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol. 2007; 62(3):251-67. DOI: 10.1016/j.critrevonc.2006.07.005. View

Rathod S, Livergant J, Klein J, Witterick I, Ringash J . A systematic review of quality of life in head and neck cancer treated with surgery with or without adjuvant treatment. Oral Oncol. 2015; 51(10):888-900. DOI: 10.1016/j.oraloncology.2015.07.002. View

Cheung Y, Goh C, Thumboo J, Khoo K, Wee J . Quality of life scores differed according to mode of administration in a review of three major oncology questionnaires. J Clin Epidemiol. 2006; 59(2):185-91. DOI: 10.1016/j.jclinepi.2005.06.011. View

DAntonio L, Zimmerman G, Cella D, Long S . Quality of life and functional status measures in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1996; 122(5):482-7. DOI: 10.1001/archotol.1996.01890170018005. View

Nie M, Liu C, Pan Y, Jiang C, Li B, Yu X . Development and evaluation of oral Cancer quality-of-life questionnaire (QOL-OC). BMC Cancer. 2018; 18(1):523. PMC: 5934940. DOI: 10.1186/s12885-018-4378-6. View

Singer S, Arraras J, Chie W, Fisher S, Galalae R, Hammerlid E . Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review. Qual Life Res. 2012; 22(8):1927-41. DOI: 10.1007/s11136-012-0325-1. View

List M, DAntonio L, Cella D, Siston A, Mumby P, Haraf D . The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer. 1996; 77(11):2294-301. DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S. View

10.

Weymuller Jr E, Alsarraf R, Yueh B, Deleyiannis F, Coltrera M . Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg. 2001; 127(5):489-93. DOI: 10.1001/archotol.127.5.489. View

11.

Terrell J, Nanavati K, Esclamado R, Bishop J, Bradford C, Wolf G . Head and neck cancer-specific quality of life: instrument validation. Arch Otolaryngol Head Neck Surg. 1997; 123(10):1125-32. DOI: 10.1001/archotol.1997.01900100101014. View

12.

Funk G, Karnell L, Christensen A, Moran P, Ricks J . Comprehensive head and neck oncology health status assessment. Head Neck. 2003; 25(7):561-75. DOI: 10.1002/hed.10245. View

13.

Patel N, Har-El G, Rosenfeld R . Quality of life after great auricular nerve sacrifice during parotidectomy. Arch Otolaryngol Head Neck Surg. 2001; 127(7):884-8. View

14.

Baumann I, Cerman Z, Sertel S, Skevas T, Klingmann C, Plinkert P . [Development and validation of the Parotidectomy Outcome Inventory 8 (POI-8). Measurement of quality of life after parotidectomy in benign diseases]. HNO. 2009; 57(9):884-8. DOI: 10.1007/s00106-009-1991-3. View

15.

Ojo B, Genden E, Teng M, Milbury K, Misiukiewicz K, Badr H . A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncol. 2012; 48(10):923-937. PMC: 3406264. DOI: 10.1016/j.oraloncology.2012.03.025. View

16.

Laraway D, Rogers S . A structured review of journal articles reporting outcomes using the University of Washington Quality of Life Scale. Br J Oral Maxillofac Surg. 2011; 50(2):122-31. DOI: 10.1016/j.bjoms.2010.12.005. View

17.

Fang F, Chien C, Kuo S, Chiu H, Wang C . Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy. Acta Oncol. 2004; 43(6):571-8. DOI: 10.1080/02841860410018430. View

18.

Becker C, Pfeiffer J, Lange K, Dahlem K . Health-related quality of life in patients with major salivary gland carcinoma. Eur Arch Otorhinolaryngol. 2018; 275(4):997-1003. DOI: 10.1007/s00405-018-4914-7. View

19.

Beutner D, Wittekindt C, Dinh S, Huttenbrink K, Guntinas-Lichius O . Impact of lateral parotidectomy for benign tumors on quality of life. Acta Otolaryngol. 2006; 126(10):1091-5. DOI: 10.1080/00016480600606731. View

20.

Eisbruch A, Kim H, Terrell J, Marsh L, Dawson L, Ship J . Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001; 50(3):695-704. DOI: 10.1016/s0360-3016(01)01512-7. View